Visiongain Publishes Dental Implants Market Report 2020-2030

07 June 2020
Pharma

Visiongain has launched a new pharma report Dental Implants Market Report 2020-2030: Forecasts by Type (Titanium Implants, Zirconia Implants), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).

The global dental implants market is anticipated to grow at a lucrative CAGR of xyz% and anticipated to reach USD xyz billion by 2020 owing to the growing demand for prosthetics, the growing burden of geriatric population coupled with riding dental diseases.

Dental implants are artificial tooth roots that can be inserted into the jaw, replacing the missing tooth. They fuse with the underlying bone in a process called osseointegration and function as the natural tooth, thereby preserving the jaw structure by preventing bone resorption or atrophy.
Dental implants can be made of materials such as titanium or zirconium and are inserted into the jawbone to supporting tooth prostheses. Implant procedures can be carried out on a single tooth or multiple teeth, depending on the bone quantity available. The availability of Small-Diameter Implants (SDIs) has further simplified the challenge of multiple implants, as they can be carried out even on limited bone volume and in narrow spaces.

The growing concern over oral hygiene and an increasing life expectancy has resulted in higher procedure volumes. An increasingly elderly population is also fueling the demand for dental implants. Growth in surgical procedural volumes increased patient awareness, and technological advances will, in turn, boost the growth of the dental implants market. Several companies are capitalizing on the growth opportunities offered by the dental implants market, both in developed nations such as the US and in emerging markets, by launching products with advanced features.

The growing number of dental injuries is anticipated to boost the market growth for dental implants. As per the Journal of the American Dental Association (JADA), it was reported that 13-39% of all dental injuries are sports-related. Dental implants help replace missing or damaged teeth in cases of dental injuries.

North America dominated the global dental implants market owing to the presence of major players, the presence of well-established dental facilities. Also, the government has launched affordable dental care services for children across the United States. Furthermore, rising awareness, growing initiatives to educate people regarding dental implants is anticipated to augur market growth over the forecast period. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to the growing presence of cancer cases in markets such as India and China. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the dental implants market growth over the forecast period.

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global dental implants market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the dental implants market.

For instance, in July 2018, The INSTITUT STRAUMANN AG acquired a 30% stake in its biomaterials partner Botiss Medical AG (Germany) for an undisclosed sum. The acquisition agreement enables INSTITUT STRAUMANN AG (Germany) in expanding its global distribution network of Botiss Medical AG products and its products. This expansion will benefit the dental implant market.

The comprehensive market report features companies such as Anthogyr SAS, Bicon, LLC, BioHorizons IPH, Inc., Cortex Dental Implants Industries Ltd., DENTIS, DENTIUM Co., Ltd., DENTSPLY Sirona, KYOCERA Medical Corporation, Leader Italia, Neobiotech Inc., Nobel Biocare Services AG., OSSTEM IMPLANT, Sweden & Martina S.p.A., The Straumann Group., T-Plus Implant Tech. Co., Zimmer Biomet Holdings, Inc., among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Influenza Vaccines Market Report 2020-2030

For the companies operating in the global influenza vaccines market, there is an immense opportunity from emerging economies across the globe.

30 September 2020

Read

Visiongain Publishes Next-Generation Pharmaceutical Temperature Management Solutions Market Report 2020-2030

Maintaining the quality and safety of the product in the supply chain has always been a high priority for pharmaceutical companies. New market dynamics including an evolving product line, more stringent regulations, geographically connected supply chains, rising risk, and extreme cost pressure have raised stakes significantly.

28 September 2020

Read

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

Read

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever